Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.7 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.7 |